Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Aquestive Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 152 | 179 | +27 |
| Shares | 66.1M | 72.3M | +6.25M (+9.5%) |
| Value | $369.3M | $467.0M | +$97.7M (+26.4%) |
New holders (48)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (21)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Nantahala Capital Management, LLC | 600,000 | $3.35M |
| Marshall Wace, LLP | 371,066 | $2.07M |
| Harvey Capital Management Inc | 343,755 | $1.92M |
| Gsa Capital Partners LLP | 241,359 | $1.35M |
| Virtu Financial LLC | 118,329 | $661.0K |
| Stonepine Capital Management, LLC | 100,600 | $562.4K |
| Pale Fire Capital SE | 93,132 | $520.6K |
| Longaeva Partners L.P. | 71,015 | $397.0K |
| XTX Topco Ltd | 60,776 | $339.7K |
| Simplex Trading, LLC | 51,177 | $286.0K |
| PharVision Advisers, LLC | 46,450 | $259.7K |
| Oxford Asset Management LLP | 41,415 | $231.5K |
| ExodusPoint Capital Management, LP | 38,103 | $213.0K |
| Oppenheimer & Co Inc | 33,532 | $187.4K |
| Quarry LP | 32,427 | $181.3K |
| Mercer Global Advisors Inc | 15,081 | $84.3K |
| Quinn Opportunity Partners LLC | 10,100 | $56.5K |
| Park Circle Co | 2,500 | $14.0K |
| Steward Partners Investment Advisory, LLC | 2,500 | $14.0K |
| Bell Investment Advisors, Inc | 500 | $2.79K |
| Your Advocates Ltd., LLP | 200 | $1.12K |